Novartis settles litigation agreement with Acura

wpid-curata__476b9545b4f7a56eb25a2c41f7a705f5.jpg

Novartis recently announced that its generic arm, Sandoz, entered into a settlement agreement with Acura Pharmaceuticals Inc. regarding Acura’s patent infringement suit against Novartis. The suit was related to Sandoz’s Abbreviated New Drug Application filing with the US Food and Drug Administration for a generic version of Acura’s Aversion Oxycodone.

Read the source article at Yahoo! Finance

About the Author

Leave a Reply